Guy Van de Weyer

G&H Wire Co., Inc. manufactures orthodontic products. It offers wire products, brackets, bands, tubes, elastomerics, and other orthodontic supplies. The company is headquartered in Franklin, IN.

Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts.

Innovia LLC designs and provides medical devices and polymers. It specializes in the development and manufacture of novel biomaterials and innovative medical devices. The company was founded by Leonard Pinchuk and John B. Martin in 2002 and is headquartered in Miami, FL.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL.

Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017.

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA.